Literature DB >> 19328919

Increased signs of acute rejection with ischemic time in a rat musculocutaneous allotransplant model.

S P Pradka1, Y S Ong, Y Zhang, S J Davis, A Baccarani, C Messmer, T A Fields, D Erdmann, B Klitzman, L S Levin.   

Abstract

BACKGROUND: Composite tissue allotransplantation (CTA) may restore a variety of tissue defects, but carries the potential risks of graft failure and/or immunosuppression-related complications. Ischemia-reperfusion injury has been documented in CTA is known to contribute to acute rejection of solid organ grafts. This study describes the influence of subcritical ischemic time (ie, ischemia sufficient to generate reversible cell damage) on signs of rejection of musculocutaneous allograft components of subcritical ischemic time, namely, ischemia sufficient to generate reversible cell injury. Although skin is considered the most antigenic component of a composite allograft and is currently used for rejection surveillance, muscle and adipose are more susceptible to ischemia-related injury.
METHODS: Vascularized epigastric flaps were transplanted from WKY to Fisher 344 rats after 1 or 3 hours of ischemia. Biopsies taken on postoperative day 6 were graded for signs of acute rejection according to criteria modified from previously published grading systems for CTA rejection.
RESULTS: Skin and muscle exposed to 3 hours of ischemia showed significantly higher rejection scores than after 1 hour of ischemia, as evidenced by a more aggressive diffuse lymphocytic infiltration with disruption of tissue architecture. The rejection score in skin with 3-hour ischemia was 5.0 +/- 0.1 versus 3.7 +/- 0.2 with 1-hour (Mann-Whitney U test; P < .05). The rejection score in muscle exposed to 3-hour ischemia was 3.6 +/- 0.3 versus 2.5 +/- 0.1 with 1-hour (P < .05).
CONCLUSIONS: Muscle and skin demonstrated increased acute rejection of allotransplants with increased subcritical ischemic time. This study supports the use of aggressive methods to reduce subcritical ischemic injury during allotransplantation of composite tissue and inclusion of muscle in postoperative biopsies in this early investigational period of CTA.

Entities:  

Mesh:

Year:  2009        PMID: 19328919     DOI: 10.1016/j.transproceed.2009.01.021

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  8 in total

1.  Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.

Authors:  Peng Zhu; Stefanie R Bailey; Biao Lei; Chrystal M Paulos; Carl Atkinson; Stephen Tomlinson
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

2.  Ex-Vivo Normothermic Limb Perfusion With a Hemoglobin-Based Oxygen Carrier Perfusate.

Authors:  Sayf A Said; Carlos X Ordeñana; Majid Rezaei; Brian A Figueroa; Srinivasan Dasarathy; Henri Brunengraber; Antonio Rampazzo; Bahar Bassiri Gharb
Journal:  Mil Med       Date:  2020-01-07       Impact factor: 1.437

3.  Current status of vascularized composite tissue allotransplantation.

Authors:  Karoline Edtinger; Xiaoyong Yang; Hanae Uehara; Stefan G Tullius
Journal:  Burns Trauma       Date:  2014-04-06

4.  Enhanced Drug Delivery to the Skin Using Liposomes.

Authors:  Gert Blueschke; Alina Boico; Ayele H Negussie; Pavel Yarmolenko; Bradford J Wood; Ivan Spasojevic; Ping Fan; Detlev Erdmann; Thies Schroeder; Michael Sauerbier; Bruce Klitzman
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-07-09

5.  Evaluation of Early Markers of Ischemia-reperfusion Injury and Preservation Solutions in a Modified Hindlimb Model of Vascularized Composite Allotransplantation.

Authors:  Sara Rostami; Michael Xu; Shaishav Datta; Siba Haykal
Journal:  Transplant Direct       Date:  2021-12-13

Review 6.  Improving the ischemia-reperfusion injury in vascularized composite allotransplantation: Clinical experience and experimental implications.

Authors:  Jiqiang He; Umar Zeb Khan; Liming Qing; Panfeng Wu; Juyu Tang
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

7.  A new rat model for orthotopic abdominal wall allotransplantation.

Authors:  William W Lao; Yen-Ling Wang; Alejandro E Ramirez; Hui-Yun Cheng; Fu-Chan Wei
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-05-07

8.  Wound complication after modified Ravitch for pectus excavatum: A case of conservative treatment enhanced by pectoralis muscle transposition.

Authors:  Beatrice Aramini; Uliano Morandi; Giorgio De Santis; Lucio Brugioni; Alessandro Stefani; Ciro Ruggiero; Alessio Baccarani
Journal:  Int J Surg Case Rep       Date:  2019-12-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.